Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT

Summit Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-746.08M -240.75M -221.31M -196.68M -161.69M -116.03M -614.93M -597.59M -597.71M -599.76M -78.78M -86.65M -84.87M -92.51M -88.6M -74.94M -73.19M -62.79M
Depreciation & Amortization
-3.88M -2.88M 89K 672K 1.25M 1.7M 1.76M 1.76M 1.87M 1.99M 2.51M 2.59M 2.51M 2.58M 2.46M 2.44M 2.27M 2.06M
Stock-Based Compensation
520.27M 52.57M 49.01M 44.86M 26.07M 16.45M 11.7M 7.03M 8.96M 9.98M 11.2M 14.62M 14.76M 15.93M 12.8M 7.76M 5.48M 2.34M
Other Working Capital
45.75K 6.22M 12.67M 23.93M 16.18M -3.9M -5.5M 1.47M 7.68M 20.1M 15.61M 10.74M -2.45M -2.67M 2.78M -7.42M 1.55M -2.01M
Other Non-Cash Items
20.84M 27.43M 38.27M 35.91M 38.39M 10.75M 526.69M 535.61M 537.49M 538.12M 11.76M 3.75M 2.94M 2.64M 823K -487K -710K 1.93M
Deferred Income Tax
n/a n/a n/a -648K 1.04M -2.38M -2.38M -1.73M -3.42M n/a 1.04M 2.01M 2.86M 3.08M 326K -979K -620K 2.27M
Change in Working Capital
1.83M 4.81M 15.2M 24.46M 18.94M 2.36M -2.02M 1.83M 5.89M 11.88M 8.62M 7.09M -8.67M -597K -67K -6.15M 1.69M -4.03M
Operating Cash Flow
-207.03M -173.14M -142.11M -112.89M -97.34M -93.76M -76.76M -52.11M -45.77M -35.71M -41.58M -55.95M -70.96M -70.92M -72.59M -71.38M -64.46M -60.49M
Capital Expenditures
-494.16K -557K -139K -126.84K -121.84K -79K -128K 868.38K 941.38K 668.38K 360.38K -754K -770K -628K -306K -236K -284K -271.98K
Cash Acquisitions
n/a n/a n/a -4.86K -3.87K 225.56K 225.56K 230.42K 229.42K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-317.91M -587.05M -680.03M -530.54M -474.98M -244.01M -321.02M -321.02M -208.16M -170M n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
618.76M 537.51M 489.84M 317.42M 352.41M 321.6M 208.74M 148.17M 38.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-14.57M -14.57M 1.12M 1.12M 15.69M 15.11M -475.59M -476.58M -476.58M -476M -984.38K n/a n/a n/a n/a n/a 168K 157.1K
Investing Cash Flow
285.79M -64.67M -204.91M -227.82M -122.69M 77.16M -587.77M -648.33M -644.83M -645.33M -624K -754K -770K -628K -306K -236K -284K -273.21K
Debt Repayment
-100M -100M -100M -75.5M n/a -373.92K -25.06M 494.94M 469.94M 469.51M 519.19M -808.01K 24.19M -30M n/a n/a n/a 55M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
11.68M 9.94M 10.42M 8.86M 7.45M 7.26M 111.57M 105.38M 205.15M 204.85M 100.24M 101.44M 2.12M 77.21M 77.92M 77.2M 76.53M 1.51M
Financial Cash Flow
190.43M 387.94M 380.74M 410.61M 206.69M 6.89M 86.51M 600.32M 675.09M 674.35M 619.43M 100.63M 26.31M 47.21M 77.92M 127.2M 126.53M 106.5M
Net Cash Flow
269.44M 150.23M 33.76M 70.31M -13.36M -9.36M -577.18M -98.18M -15.22M -6.48M 576.82M 41.72M -46.05M -24.74M 5.37M 58.98M 3.13M -16.57M
Free Cash Flow
-207.38M -173.54M -142.09M -112.87M -97.46M -93.84M -76.89M -51.24M -44.83M -35.04M -41.22M -56.71M -71.73M -71.55M -72.89M -71.61M -64.75M -60.76M